Harpoon Therapeutics Inc (HARP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HARP | AKBA | FDMT | ||
| Company | Harpoon Therapeutics Inc | Akebia Therapeutics | 4D Molecular Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.00 | 1.8100 | 8.41 | ||
| High | 23.02 | 1.8300 | 8.48 | ||
| Low | 22.99 | 1.7500 | 7.82 | ||
| Last | 23.01 | 1.8200 | 7.99 | ||
| Change | +0.02 | +0.0300 | -0.42 | ||
| % Change | +0.09% | +1.68% | -4.99% | ||
| Volume | 6,624,300 | 1,444,200 | 942,800 | ||
| 20-Day Average Volume | 1,788,445 | 2,400,435 | 803,835 | ||
| Previous Close | 22.99 | 1.7900 | 8.41 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.76 | 1.8118 | 8.23 | ||
| 20-Day Raw Stochastic | 77.53% | 55.56% | 36.02% | ||
| 20-Day Relative Strength | 80.05% | 58.76% | 38.51% | ||
| Weighted Alpha | +102.30 | +34.63 | -49.31 | ||
| Today's Opinion | 100% Buy | 100% Buy | 96% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 80% Sell | ||
| Last Month's Opinion | 88% Buy | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.31% since 03/01/24 | -2.15% since 11/14/24 | -0.37% since 11/14/24 | ||
| Low | 22.95 on 03/04/24 | 1.7500 on 11/21/24 | 7.82 on 11/21/24 | ||
| High | 23.21 on 03/07/24 | 1.8700 on 11/15/24 | 9.18 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | +3.00% since 02/08/24 | +32.85% since 10/21/24 | -6.88% since 10/21/24 | ||
| Low | 22.32 on 02/09/24 | 1.3900 on 10/22/24 | 7.32 on 11/14/24 | ||
| High | 23.21 on 03/07/24 | 2.0200 on 11/11/24 | 9.18 on 11/18/24 | ||
| 3-Month | |||||
| %Chg | +157.38% since 12/08/23 | +22.15% since 08/21/24 | -47.40% since 08/21/24 | ||
| Low | 8.44 on 12/12/23 | 1.2400 on 10/01/24 | 7.32 on 11/14/24 | ||
| High | 23.21 on 03/07/24 | 2.0200 on 11/11/24 | 17.41 on 09/19/24 | ||
| 6-Month | |||||
| %Chg | +195.00% since 09/08/23 | +61.06% since 05/21/24 | -68.23% since 05/21/24 | ||
| Low | 3.11 on 10/12/23 | 0.8000 on 06/26/24 | 7.32 on 11/14/24 | ||
| High | 23.21 on 03/07/24 | 2.0200 on 11/11/24 | 28.93 on 07/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 389,605 | 390,544 | 388,777 | ||
| Shares Outstanding, K | 16,932 | 218,181 | 46,228 | ||
| Annual Sales | 31,920,000 | 194,620,000 | 20,720,000 | ||
| Annual Net Income | -67,730,000 | -51,930,000 | -100,840,000 | ||
| Last Quarter Sales | 4,450,000 | 37,430,000 | 10,000 | ||
| Last Quarter Net Income | -1,800,000 | -20,040,000 | -34,950,000 | ||
| 60-Month Beta | 2.11 | 0.74 | 2.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.46 on 11/09/23 | -0.10 on 11/07/24 | -0.79 on 11/13/24 | ||
| Latest Earnings Date | 03/25/24 | 11/07/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||